SEC Form 4 · accession 0001225208-18-012151

Merck & Co., Inc. · MRK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman, President & CEO · Director

Period of report

Jul 31, 2018

Accepted (ET)

Aug 1, 2018 · 5:12 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000310158

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Jul 31, 2018	M	228,091	$33.49	A	938,788	D
Common Stock^F2,F3	Jul 31, 2018	S	228,091	$65.0034	D	710,697	D
Common Stock	Jul 31, 2018	G	18,747	$0.00	D	691,950	D
Common Stock - 401(k) Plan^F4	holding	—	—		—	3,962	I	By 401(k)

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F5	$33.49	Jul 31, 2018	M	228,091	D	May 7, 2011	May 6, 2020	Common Stock	228,091	0	D

F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.05, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
F3Holdings include shares acquired in dividend reinvestment transactions.
F4Includes shares acquired and dividends earned through July 9, 2018, in the Merck U.S. Savings Plan, a 401(k) plan.
F5The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.